FDA 483 - SHREEPATI PHARMACEUTICALS PRIVATE LIMITED - December 02, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Shreepati Pharmaceuticals Private Ltd. in Dhar District, Madhya Pradesh, India, an intermediate manufacturer, revealed significant deficiencies. Observations included contaminated manufacturing equipment, lack of stability data for intermediates, failure to retain essential records and reserve samples, and inadequate demonstration of water system suitability. These issues highlight serious concerns regarding the firm's quality control and manufacturing processes.
ID · a213dc5b-0bf4-4176-8798-f9912fac4fd6